Kabicilas 500mg/500mg Injection
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Kabicilas 500mg/500mg Injection
Combiflox 500mg/500mg Injection, a dual-antibiotic formulation, combats serious bacterial infections. Administered only by a healthcare provider, this medication targets infectious microorganisms, preventing infection spread. Complete the prescribed treatment regimen, even with symptom improvement, and attend all scheduled appointments. Common side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) are possible but usually resolve. Report any worsening side effects or allergic reactions (rash, itching, swelling, breathing difficulty) immediately. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, refrain from driving if experiencing drowsiness or dizziness.
Uses of Kabicilas 500mg/500mg Injection
Life-threatening bacterial infestations
Major Benefits of Kabicilas 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kabicilas 500mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Kabicilas 500mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Kabicilas 500mg/500mg Injection works:
The injectable formulation, Kabicilas 500mg/500mg, unites imipenem, a bacterial growth inhibitor, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's mechanism involves disrupting the synthesis of crucial bacterial cell wall components, thus hindering bacterial survival. Cilastatin's role is to prevent the premature degradation of imipenem by dehydropeptidase I, thereby extending imipenem's therapeutic efficacy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kabicilas 500mg/500mg Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Kabicilas 500mg/500mg Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Kabicilas 500mg/500mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingUNSAFE
Administering Kabicilas 500mg/500mg Injection might induce adverse reactions impairing driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), may impact some individuals' ability to operate a vehicle safely.
KidneyCAUTION
Patients with kidney impairment should use the 500mg/500mg Kabicilas Injection cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Kabicilas 500mg/500mg Injection to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Kabicilas 500mg/500mg Injection :
Omit a scheduled Kabicilas 500mg/500mg Injection? Seek medical advice immediately.
Facts to Know About Kabicilas 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently